Associated risk factors with disease severity and antiviral drug therapy in patients with COVID-19
2021 · BMC Infectious Diseases · 13 citations
https://doi.org/10.1186/s12879-021-06282-6
S
Shiwei Kang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
43
Citations
4
h-index
2
i10-index
Shiwei Kang is an academic researcher from North China University of Science and Technology. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Adipokines, Inflammation, and Metabolic Diseases. The author has an h-index of 4, co-authored 17 publications.
Papers by this author
worksLianhua Qingke Tablet in severe pneumonia: Clinical efficacy and immunoregulatory mechanisms
2025 · Journal of Ethnopharmacology · 4 citations
https://doi.org/10.1016/j.jep.2025.119420
Notoginsenoside R1 Improved Hypoxic Pulmonary Hypertension by Inhibiting Glycolysis‐Mediated Pulmonary Arterial Vascular Remodeling
2025 · Canadian Respiratory Journal · 1 citations
https://doi.org/10.1155/carj/2884885
Cumulative Insulin Resistance Metabolic Score and Heart Failure Risk: A Prospective Study
2026 · Nutrition Metabolism and Cardiovascular Diseases · 0 citations
https://doi.org/10.1016/j.numecd.2026.104634
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat